Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Revenues:        
Revenues $ 2,983,887 $ 2,352,630 $ 5,708,311 $ 4,436,468
Costs and expenses:        
Costs of revenues 1,208,786 908,162 2,250,012 1,721,786
Research and development 332,826 265,031 651,341 523,184
Selling, general and administrative 243,096 213,479 497,076 406,740
Interest expense 74,280 37,852 148,675 76,164
Loss on extinguishment of debt 0 0 13,286 0
Other expense (income), net (18,074) 1,201 (65,080) 15,341
Income before income taxes 1,142,973 926,905 2,213,001 1,693,253
Provision (benefit) for income taxes 164,178 209,388 208,141 (92,749)
Net income 978,795 717,517 2,004,860 1,786,002
Less: Net income attributable to non-controlling interest 0 73 74 141
Net income attributable to KLA $ 978,795 $ 717,444 $ 2,004,786 $ 1,785,861
Net income per share attributable to KLA        
Basic (in dollars per share) $ 6.93 $ 4.74 $ 14.16 $ 11.77
Diluted (in dollars per share) $ 6.89 $ 4.71 $ 14.09 $ 11.68
Weighted-average number of shares:        
Basic (in shares) 141,299 151,251 141,564 151,791
Diluted (in shares) 141,966 152,331 142,268 152,886
Product        
Revenues:        
Revenues $ 2,463,408 $ 1,895,769 $ 4,659,017 $ 3,525,657
Service        
Revenues:        
Revenues $ 520,479 $ 456,861 $ 1,049,294 $ 910,811